Craft

IDS

Revenue

£39.3 M

FY, 2020

IDS Summary

Company Summary

Overview
IDS (also known as Immunodiagnostic Systems Holdings) is a medical diagnostics business that develops and provides automated and manual assays. It focuses on the clinical areas of bone and calcium metabolism, growth, hypertension, and chronic kidney disease.
Type
Subsidiary
Status
Active
Founded
1977
HQ
Boldon Colliery, GB | view all locations
Website
http://www.idsplc.com
Cybersecurity rating
Sectors

Key People

  • Jaap Stuut

    Jaap Stuut, Chief Executive Officer

  • Gareth Dixon

    Gareth Dixon, Group Finance Director (IDS)

  • Wolfgang Schlumberger

    Wolfgang Schlumberger, Chief Executive Officer (Euroimmun)

    LocationsView all

    29 locations detected

    • Boldon Colliery, England HQ

      United Kingdom

      10 Didcot Way

    • Gaithersburg, MD

      United States

      940 Clopper Rd #948

    • Scottsdale, AZ

      United States

      8425 N 90th St #8

    • Liège, Wallonie

      Belgium

      Rue Ernest Solvay 101

    • SP

      Brazil

      R. Domingos de Morais, 2781 - Vila Mariana

    • Markham, ON

      Canada

      50 Valleywood Dr

    and 23 others

    IDS Financials

    Summary Financials

    Revenue (H1, 2021)
    £13.7M
    Gross profit (H1, 2021)
    £7.5M
    Net income (H1, 2021)
    (£3.0M)
    Cash (H1, 2021)
    £24.2M
    EBIT (H1, 2021)
    (£3.5M)

    Footer menu